Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Polynovo Limited

PNV.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Medical Equipment, Supplies & Distribution ·

Australia Small Cap Analyst: BUY

Last Close

$0.71

▼ -1.00%

Market Cap $489.29M · Vol 1.01M

Key Metrics

P/E Ratio

93.22

FWD: 51.02

Market Cap

$489.29M

Small Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

+57.95%

YoY

RSI (14)

39.62

Momentum

Beta

1.83

vs Market

52W High

$1.19

35.14% below

52W Low

$0.58

25.64% above

Volume

1.01M

Avg 2.29M

P/B

7.01

Price-to-book

ROE

8.44%

Return on equity

Free Float

88.97%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Polynovo Limited (PNV.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PNV.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.88%

+4.21%

-1.98%

+4.21%

YTD

-19.51%

-32.19%

-17.25%

-48.30%

Financials & Valuation

TTM · Annual

Total Revenue	$99.52M
Net Income	$5.08M
Revenue Growth (YoY)	+8.40%
Gross Margin	87.55%
Operating Margin	7.37%
Net Profit Margin	5.10%
ROE	8.44%
ROA · ROIC	6.02% · 7.86%

P/E Ratio	93.22
Forward P/E (FY1)	51.02
PEG Ratio	-1.95
P/S	4.42
P/B	7.01
P/FCF	67.26
EPS Growth	+57.95%
Outstanding Shares	690.84M

Technical Indicators

50-Day SMA	$0.70
200-Day SMA	$0.74
RSI (14)	39.62
Beta	1.83
52-Week High	$1.19
52-Week Low	$0.58

Volume Today	1.01M
Avg Daily Volume (30D)	2.29M
Relative Volume	0.44x
Volatility (10D)	32.57
Volatility (30D)	45.37
Free Float	88.97%

Analyst Consensus

BUY

Current Price $0.71

Mean Target $0.90

52W Low$0.58 52W High$1.19

Current

Target

$0.58 $1.19

Current Analyst target

+26.76% upside potential · 7 analysts

Identifiers

ExchangeASX

FIGIBBG001SC4DT6

ISINAU000000PNV0

CountryAustralia

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateFeb 18, 2027

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

ABT Abbott Laboratories -1.36% MDT Medtronic PLC -0.72% COR Cencora, Inc. +0.19% 7741.T HOYA CORPORATION -1.92% BDX Becton Dickinson and Co +0.81%

Company Profile

PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.